Comparing Two Training Methods for Opioid Wizard

NCT04867382 | Completed Results

• 2 other identifiers: A20-1563UG1DA040316-06S4
• Study Type: interventional
• Target: 88
• Locations: 1 country
• Sites: 1

Brief Summary

The prevalence of opioid use disorder (OUD) and opioid-related deaths has risen dramatically in recent years. Effective treatments, including medications for opioid use disorder (MOUDs; e.g., buprenorphine-naloxone and methadone) are under-utilized. There are few evidence-based interventions for changing attitudes toward Opioid Use Disorder (OUD) in the general public and especially among healthcare clinicians. This study proposed an innovative intervention to change attitudes of Primary Care Clinicians (PCCs) toward persons with OUD. Study participants were stratified into one of two online learning courses: the intervention training was compared with an attention-control training.

Conditions

Opioid-use Disorder; Opioid Dependence; Attitude of Health Personnel

Outcome Measures

Primary Outcomes (1)

• Difference, Disdain, and Blame Scales

  Attitudes toward people with OUD were measured using the Difference, Disdain, and Blame scales, which measure attitudes toward people with mental illness and substance use disorders (SUDs). Difference, Disdain, and Blame scales measured stigma toward people with OUD, with three questions in each domain. Items are scored on a 9-point agreement scale. The range is 1-9; some items are reverse-scored. Items are averaged to obtain a score, with higher scores reflecting more stigma (range = 1-9). Evidence suggests that the scales demonstrate good internal consistency and are positively associated.

  Immediately after completing online training.

Secondary Outcomes (3)

• Intentions to Get Waivered to Prescribe Buprenorphine.

  Immediately after completing online training

• Intentions to Prescribe Buprenorphine Should a Waiver no Longer be Required.

  Immediately after completing online training

• Opioid Wizard Use

  Six months following online training.

Study Arms (2)

Intervention

EXPERIMENTAL

This arm received a case-based training on how to use the Opioid Wizard tool, including patient narratives and videos and person-first language.

Behavioral: Online training

Comparison training

PLACEBO COMPARATOR

This arm received a case-based training on how to use the Opioid Wizard tool.

Behavioral: Online training

Interventions

Online training BEHAVIORAL

This intervention consisted of two different interactive online trainings delivered through an online learning platform at HealthPartners.

Comparison training; Intervention

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Primary Care Clinician: Had to be a family physician, general internist, adult-care non-obstetric nurse practitioner, or a physician assistant
• Had to practice at a study-eligible primary care clinic already involved in the main study intervention arm

You may not qualify if:

• PCCs were ineligible to participate if they had fewer than 5 eligible patient encounters between Sep 2020 and Feb 2021.

Sponsors & Collaborators

• HealthPartners Institute: lead
• Hennepin Healthcare Research Institute: collaborator
• National Institute on Drug Abuse (NIDA): collaborator

Study Sites (1)

HealthPartners

Bloomington, Minnesota, 55425-4516, United States

Location

Related Publications (1)

• Hooker SA, Crain AL, LaFrance AB, Kane S, Fokuo JK, Bart G, Rossom RC. A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians. Addict Sci Clin Pract. 2023 Feb 11;18(1):10. doi: 10.1186/s13722-023-00366-1.

  PMID: 36774521 DERIVED

MeSH Terms

Conditions

Opioid-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related Disorders; Substance-Related Disorders; Chemically-Induced Disorders; Mental Disorders

Limitations and Caveats

The online training meant there was no way for the research team to control for PCC engagement with content. The training, at 25-35 minutes, may not have been intensive enough to have substantial impact. The comparison training, which lasted the same amount of time and covered some of the same topics, may have had an effect on PCCs. The study did not include a baseline training to avoid signaling the primary outcome was stigma, so there is no way to measure pre-training attitudes.

Results Point of Contact

• Title: Stephanie Hooker, PhD, MPH, MS, Principal Investigator
• Organization: HealthPartners Institute

Stephanie.A.HookerShowalter@HealthPartners.com

(952) 967-5056

Study Officials

• Stephanie Hooker, PhD, MPH, MS

  HealthPartners Institute

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: Methods for concealment of allocation. PCCs were blind to their randomized MyLearning training assignment. The study statistician generated the randomization assignment, and a study team member submitted that list to HealthPartners (HP) MyLearning staff. Study team members collecting outcome data from surveys, Opioid Wizard, and Epic (including use rates, buprenorphine prescriptions) also were blinded to treatment assignment.
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: This study used a randomized controlled trial (RCT) design embedded in a larger, multisite trial of a clinical decision support (CDS) tool to help PCCs identify, diagnose, and treat patients with OUD. PCCs in clinics randomized to Opioid Wizard were randomized 1:1 to the intervention or comparison training and stratified by clinic.

Study Record Dates

• First Submitted: April 27, 2021
• First Posted: April 30, 2021
• Study Start: April 9, 2021
• Primary Completion: September 10, 2021
• Study Completion: November 30, 2021
• Last Updated: December 15, 2022
• Results First Posted: December 15, 2022

Record last verified: 2021-08

Data Sharing

• IPD Sharing: Will share
• Time Frame: Pending
• Access Criteria: You will not need to log in in order to: browse the study metadata on the Discovery Page or read the pre-made tutorial notebooks in the "Example Analysis" tab. You will need to log in and obtain authorization (access) in order to: register your own study; access studies with controlled data perform analyses in workspaces; and download data files and file manifests. run interactive tutorial notebooks in workspaces

Locations

US (1)